Beryl Drugs Cash Flow Annual

BSE: 524606 | NSE: - | ISIN: INE415H01017 | Sector: Biotechnology & Drugs
18.82 0.00 (0.00%)Updated : 23 Jun 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Net Income/ Starting Line 0.871.010.98-0.95
Depreciation/ Depletion 1.251.200.811.09
Non- Cash Items 0.400.330.290.29
Changesin Working Capital 0.13-1.720.39-0.72
Cashfrom Operating Activities 2.640.822.48-0.29
Capital Expenditures -2.19-1.35-1.56-0.42
Other Investing Cash Flow Items Total 1.790.270.260.95
Cashfrom Investing Activities -0.40-1.08-1.300.54
Financing Cash Flow Items -0.53-0.45-0.42-0.43
Issuance( Retirement)of Debt Net -1.020.55-0.750.00
Cashfrom Financing Activities -1.550.10-1.17-0.43
Net Changein Cash 0.69-0.160.01-0.18
Cash Interest Paid 0.530.460.420.43
Cash Taxes Paid 0.180.200.060.10
period Length 12.0012.0012.0012.00
period Type ----
*All figures in crores except per share values
Recommended For You
Trending Stocks
915.50+10.85(1.20%)
2,184.90+15.45(0.71%)
1,994.95+11.60(0.58%)
1,584.70-37.15 (-2.29%)
3,583.30-77.35 (-2.11%)